Navigation Links
China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2013
Date:11/5/2013

s ended September 30, 2013 mainly consisted of a payment of $29.6 million for share repurchase and a dividend of $10.9 million paid by the Company's subsidiaries to the non-controlling interest shareholders.

OutlookFor the full year of 2013, the Company expects to meet the high end of its total sales forecast range of $195 million to $205 million. Based on the Company's strong margin performance in the third quarter and favorable outlook for the remainder of the year, it is raising its full year non-GAAP adjusted net income estimate to the range of $58 million to $60 million, a 13-16% increase from the estimate provided last quarter.

This forecast reflects the Company's current and preliminary views, which are subject to change.

Conference CallThe Company will host a conference call at 7:30 am, Eastern Time on Wednesday, November 6, 2013, which is 8:30 pm, Beijing Time on November 6, 2013, to discuss third quarter 2013 results and answer questions from investors. Listeners may access the call by dialing:US:

+1 866 652 5200International:

+1 412 317 6060Hong Kong:

06 800 20175China:

400 120 1203Passcode:

10036364A telephone replay of the call will be available after the conclusion of the conference all through 9:00 am, Eastern Time on November 14, 2013. The dial-in details are:US:

+1 877 344 7529International:

+1 412 317 0088Passcode:

10036364A live and archived webcast of the conference call will be available through the Company's investor relations website at http://chinabiologic.investorroom.com.

About China Biologic Products, Inc.China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medi
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Governor-General of Australia Ms. Bryce Visits Sichuan University and Investigates Australia Cochlear Cochlea Project in West China Hospital, Sichuan University
2. The Medical Device Market: China
3. China Biologic Products to Report Third Quarter 2013 Financial Results
4. MEDTEC China 2013: Close to 8,000 Industry Professionals Make Show an Outstanding Success
5. What U.S. Doctors Know That Has Not Yet Reached China
6. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
7. Micell Technologies Announces Development and Distribution Agreement to Bring MiStent SES to China
8. China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 25, 2013
9. MEDTEC China 2013: Shaping Up to be The Most Successful Event Ever
10. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
11. Ventana receives approval from Chinas FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... LAKE FOREST, Ill. , Dec. 19, 2014 /PRNewswire/ ... the world,s leading provider of injectable drugs and infusion ... the J.P. Morgan 33rd Annual Healthcare Conference on Wednesday, ... The presentation is scheduled to begin at 10:30 ... will be available to all interested parties through a ...
(Date:12/19/2014)... Dec. 19, 2014 In today,s rapidly ... marketing communication tools are essential for survival. The ... consequently consumers, desires, preferences, and unmet needs are ... research groups across all industries are continually searching ... However, the adoption of new market research techniques ...
(Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. , Dec. ... SRNE ;  Sorrento), an oncology company developing ... Conkwest, Inc., a privately-held immuno-oncology company developing proprietary ... cell-line based therapy, announced today that the companies ... develop next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5
... for Treating Motor System Disorders, LA JOLLA, ... currently in clinical development by TorreyPines Therapeutics,Inc. (Nasdaq: ... migraine headache, was shown,in an independent study to ... rigidity in a rat model of spinal ischemia. ...
... Pharmion Corporation,(Nasdaq: PHRM ) today announced ... trial evaluating amrubicin, the Company,s third-generation,synthetic anthracycline, in ... The randomized, controlled, multi-center study will compare,amrubicin to ... SCLC in the US and EU. Enrollment in ...
Cached Medicine Technology:Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego 2Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego 3Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego 4Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 2Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 3Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 4Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer 5
(Date:12/19/2014)... 19, 2014 Silver Dollar City ... record -- for the first time ever, Silver Dollar City ... Guinness World Records 2015, listing the park’s wood coaster Outlaw ... In additional awards announced this week, Silver Dollar City is ... in the US,” USA Today’s 10Best awards for “Best Public ...
(Date:12/19/2014)... 20, 2014 These vanadium reserves are ... nations. Around 151,000 tons of vanadium were produced globally ... vanadium usage increased at 6.7% AAGR during the period ... iron industry, being the largest consumer, accounted for more ... by titanium-vanadium alloy and the chemical industry. , View ...
(Date:12/19/2014)... The print component of Vision and ... of the Toronto Star, with a circulation of approximately ... digital component is distributed nationally through a vast social ... sites and partner outlets. To explore the digital version ... publication features an exclusive interview with Mark DeMontis ...
(Date:12/19/2014)... (HealthDay News) -- All children should have their eyesight ... every year, eye experts say. The new vision-screening ... of the U.S. National Center for Children,s Vision Health. ... group require screening for eye problems, particularly vision ... ("lazy eye") and strabismus (a disorder of eye alignment). ...
(Date:12/19/2014)... -- Dense bunches of bacteria called biofilms can be found ... The researchers said these biofilms were especially prevalent ... of these biofilms may represent an increased likelihood of colon ... person,s risk for the disease, the researchers said. Like ... coat the mucus layer of cells lining the colon, according ...
Breaking Medicine News(10 mins):Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Could Bacteria Play a Role in Colon Cancer? 2
... bald mice to get fur on the body, says a ... C. Thompson and colleagues at Johns Hopkins University School// of ... encodes a protein that is essential for hair follicle regeneration. ... Hairless gene, hair growth is initially normal. But once hair ...
... but that is the place no one looks. Same is ... control protein with a key role in the brain's ability ... treating obesity and type 2 diabetes. ,The findings in ... might underlie obesity in humans, the researchers said. SH2-B, which ...
... temporarily ban the Environmental Protection Agency (EPA) from using ... marketed//. Lawmakers on Capitol Hill will soon decide whether ... and use of studies that expose participants to pesticides. ... to have their pesticides approved by the agency for ...
... living with HIV/AIDS in Manipur have hope at hand ... specialised clinics for their care and treatment//.,The Nobel prize-winning ... signed a memorandum of understanding with the Manipur government ... HIV/AIDS. ,The Dutch chapter of the MSF ...
... make some people vulnerable to suffer from the dreaded ... can diagnose the risk//. ,According to the most ... by the researchers from Vanderbilt University in Nashville, Tennessee ... Association in San Diego, a cluster of genes on ...
... help of carotid endarterectomy, said a report in the ... is the most frequently performed operation to prevent stroke//. ... prevent future stroke, according to a clinical practice guideline ... Neurology (AAN). The guideline updates the 1990 AAN statement ...
Cached Medicine News:Health News:An Answer To Obesity: Weight Control Protein 2Health News:US Senate Votes against Testing of Pesticide on Humans 2Health News:Specialized Clinics For Manipur's AIDS Patients 2Health News:Carotid Endarterectomy Beneficial for Stroke Prevention 2
... segment surgeries Vitrectomy-Lensectomy + Irrigation/Aspiration system ... Linear Aspiration. Interchangeable disposable blades can ... Easy to read LED display for ... 1- 600 cuts per minute. Independent ...
Mendez Multi-Purpose LASIK Forceps. To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps, Titanium...
Hockey Knife For PRK - Also available in Titanium...
The CGAL gonioscopic contact glass was designed by Roussel and Fankhauser for,laser treatments of the chamber angle. It reduces the laser spot by a factor of 1.5 as compared to a Goldmann Glass....
Medicine Products: